According to multiple industry sources, Apple has resumed discussions with Intel to manufacture its next-generation A-series mobile processors for the iPhone 18 lineup, potentially shifting up to 30% of its chipset volume away from TSMC by 2027. This landmark move follows Apple’s two-year hiatus from Intel and reinforces its strategy to diversify manufacturing risk. Intel is slated to leverage its newly commissioned 18-angstrom node at its Arizona Fab 42 facility, which can produce an estimated 200,000 wafers per month. Analysts estimate this partnership could reduce Apple’s overall wafer spend by up to 10%, bolstering gross margins given Intel’s short-term capacity incentives.

Wall Street consensus forecasts Apple’s fiscal first quarter revenue to rise approximately 11% year-over-year to nearly $138 billion, with GAAP earnings per share projected up 11% as well, near $2.67. Investor attention will center on iPhone 17 unit shipments—expected to reach roughly 82 million in the quarter—and growth in the services segment, which analysts forecast to exceed $24 billion, representing over 17% of total revenue. With Apple trailing peers in applied AI innovations, market participants will scrutinize any management commentary on Siri enhancements, AI wearable developments and expansion of developer tools for generative AI within iOS.

Data from J.P. Morgan Equity Strategy reveals that retail investors have net‐sold more than $4 billion of Apple shares since July 2025, marking the only member of the Magnificent Seven to see cumulative outflows over that period. This contrasts sharply with inflows into other mega-cap names, underscoring concerns among individual investors about Apple’s near-term revenue growth and pace of AI monetization. The sustained selling pressure has coincided with elevated volatility in the broader market, prompting questions about whether current sentiment presents a buying opportunity or signals further underperformance.

Bloomberg reports Apple is on track to launch a new subscription service in mid-2026—a personalized AI health coach integrated into the Apple Health app. Leveraging on-device sensors and third-party data partnerships, the service will offer nutrition guidance, medication reminders and lifestyle recommendations. Apple is reportedly investing over $500 million in machine learning infrastructure for this initiative, aiming to tap into the $50 billion global digital health market. Investors will evaluate this initiative as a measure of Apple’s ability to diversify revenue beyond hardware and traditional services.